| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2583 | Montelukast sodium, Amorphous, non-micronised and micronised | MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN | 100014794;100023345 | CEP 2012-091 - Rev 01 | 2025/02/17 | Valid | Chemical | 2025/02/17 | Monograph revision|CEP granted|17/02/2025 | ||
| 883 | Calcitriol | CERBIOS-PHARMA SA Barbengo CH | 100015546;100024284 | CEP 2012-356 - Rev 01 | 2025/02/17 | Valid | Chemical and TSE | 2025/02/17 | Monograph revision|CEP granted|17/02/2025; Minor revision|Accepted - CEP remains valid|23/08/2022; Notification|Accepted - CEP remains valid|20/09/2021 |
||
| 1563 | Simvastatin | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2001-384 - Rev 09 | 2025/02/17 | Valid | Chemical | 2025/02/17 | Minor revision|CEP granted|17/02/2025; Notification|Rejected|14/01/2025 |
||
| 2856 | Pirfenidone | ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN | 100006039;100002980 | CEP 2018-147 - Rev 02 | 2025/02/17 | Valid | Chemical | 2025/10/14 | Minor revision|Accepted - CEP remains valid|14/10/2025; Renewal|CEP granted|17/02/2025; Minor revision|CEP granted|01/02/2023; Minor revision|Accepted - CEP remains valid|04/02/2021 |
||
| 1455 | Ofloxacin | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2000-106 - Rev 10 | 2025/02/17 | Valid | Chemical | 2025/02/17 | Minor revision|CEP granted|17/02/2025; Minor revision|CEP granted|28/02/2024; Minor revision|Accepted - CEP remains valid|17/03/2022; Notification|CEP granted|29/07/2021; Minor revision|CEP granted|01/12/2020 |
||
| 2288 | Citalopram hydrobromide | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2009-248 - Rev 05 | 2025/02/17 | Valid | Chemical | 2025/02/17 | Notification|CEP granted|17/02/2025; Minor revision|CEP granted|17/06/2024; Minor revision|Accepted - CEP remains valid|04/09/2023; Minor revision|CEP granted|14/10/2021; Notification|Rejected|06/08/2021 |
||
| 2641 | Dutasteride | SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai IN | 100048889;100089578 | CEP 2022-172 - Rev 00 | 2025/02/17 | Valid | 17/02/2030 | Chemical | 2025/02/17 | New application|CEP granted|17/02/2025 | |
| 2254 | Moxifloxacin hydrochloride | CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. Chongqing CN | 100038938;100061197 | CEP 2021-458 - Rev 00 | 2025/02/17 | Valid | 17/02/2030 | Chemical | 2025/02/17 | New application|CEP granted|17/02/2025 | |
| 1575 | Tiapride hydrochloride, Process 2 | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 2014-274 - Rev 01 | 2025/02/13 | Valid | Chemical | 2025/02/13 | Notification|CEP granted|13/02/2025; Minor revision|Accepted - CEP remains valid|28/05/2024; Minor revision|Accepted - CEP remains valid|13/02/2023 |
||
| 1354 | Oxybutynin hydrochloride | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 2019-350 - Rev 01 | 2025/02/13 | Valid | 08/11/2027 | Chemical | 2025/02/13 | Notification|CEP granted|13/02/2025 | |
| 2531 | Clopidogrel hydrogen sulfate, Form-II, milled and non-milled | MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village IN | 100018316;100070723 | CEP 2019-318 - Rev 01 | 2025/02/13 | Valid | Chemical | 2025/02/13 | Renewal|CEP granted|13/02/2025 | ||
| 23 | Diphenhydramine hydrochloride | SUPRIYA LIFESCIENCE LIMITED Mumbai IN | 100015796;100024574 | CEP 2019-120 - Rev 01 | 2025/02/13 | Valid | 27/09/2027 | Chemical | 2025/02/13 | Minor revision|CEP granted|13/02/2025 | |
| 2736 | Imatinib mesilate | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2015-096 - Rev 05 | 2025/02/13 | Valid | Chemical | 2025/02/13 | Administrative procedure|CEP granted|13/02/2025; Minor revision|CEP granted|03/01/2025; Notification|CEP granted|19/07/2023; Notification|Accepted - CEP remains valid|22/11/2022; Administrative procedure|CEP granted|02/12/2021; Notification|CEP granted|22/11/2021; Minor revision|Accepted - CEP remains valid|17/09/2021; Renewal|CEP granted|24/06/2021; Minor revision|Accepted - CEP remains valid|30/06/2020 |
||
| 1272 | Tryptophan | Ajinomoto Co., Inc. Tokyo JP | 100011941;100021464 | CEP 1998-137 - Rev 07 | 2025/02/12 | Valid | Chemical | 2025/02/13 | Notification|CEP granted|13/02/2025; Notification|CEP granted|12/02/2024; Notification|CEP granted|31/03/2023 |
||
| 1137 | Pentamidine diisetionate | EMCURE PHARMACEUTICALS LIMITED Pune IN | 100011677;100022690 | CEP 2022-169 - Rev 01 | 2025/02/12 | Valid | 10/03/2028 | Chemical | 2025/02/12 | Notification|CEP granted|12/02/2025; New application|CEP granted|10/03/2023 |
|
| 2631 | Rosuvastatin calcium, AM code | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2024-400 - Rev 01 | 2025/02/12 | Valid | 14/01/2030 | Chemical | 2025/02/12 | Administrative procedure|CEP granted|12/02/2025; New application|CEP granted|14/01/2025 |
|
| 1711 | Buspirone hydrochloride | MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village IN | 100013041;100021615 | CEP 2023-395 - Rev 00 | 2025/02/12 | Valid | 12/02/2030 | Chemical | 2025/09/09 | Minor revision|Accepted - CEP remains valid|09/09/2025; New application|CEP granted|12/02/2025 |
|
| 1045 | Sulpiride | OLON S.P.A. Rodano IT | 100012085;100019537 | CEP 1998-073 - Rev 10 | 2025/02/12 | Valid | Chemical | 2025/02/12 | Notification|CEP granted|12/02/2025; Minor revision|Accepted - CEP remains valid|28/06/2024; Minor revision|Accepted - CEP remains valid|26/08/2022; Minor revision|CEP granted|27/04/2021 |
||
| 1564 | Sodium alendronate trihydrate | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2007-048 - Rev 03 | 2025/02/12 | Valid | Chemical | 2025/02/12 | Minor revision|CEP granted|12/02/2025; Notification|CEP granted|11/01/2024; Minor revision|Accepted - CEP remains valid|31/07/2023; Minor revision|Accepted - CEP remains valid|25/05/2022 |
||
| 330 | Gelatin, Acid bone gelatin | TESSENDERLO GROUP N.V. Vilvoorde BE | 100038809;100060926 | CEP 2008-187 - Rev 01 | 2025/02/12 | Valid | TSE | 2025/02/12 | Major revision|CEP granted|12/02/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号